Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study

Archives of Biological Sciences

Volumn 68, Issue 1, 2016, Pages 41-50

  Sonmez, Erdal ^a   Aydin, Elanur ^b   Turkez, Hasan ^b,d   Özbek, Elvan ^c   Togar, Basak ^a   Meral, Kadem ^a,b   Çetin, Damla ^a   Cacciatore, Ivana ^d   Di Stefano, Antonio ^d  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ERZURUM TECHNICAL UNIVERSITY   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cytotoxicity; ; Genotoxicity; Iron oxide; Lymphocyte; Oxidative stress

Indexed keywords

EID: 84961584037     PISSN: 03544664     EISSN: None     Source Type: Journal    
DOI: 10.2298/ABS141218006S     Document Type: Article

References (63)

1. Ahamed, M., Alhadlaq, H.A., Alam, J., Khan, M.A., Ali, D. and S. Alarafi (2013). Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines. Curr. Pharm. Des. 19, 6681-6690.
2. Alimpić, A., Oaldje, M., Matevski, V., Marin, P.D. and S. Duletić-Laušević (2014). Antioxidant activity, total phenolic and flavonoid contents of Salvia amplexicaulis Lam. Extracts. Arch. Biol. Sci. 66, 307-316.
3. Apopa, P.L., Qian, Y., Shao, R., Guo, N.L., Schwegler-Berry, D., Pacurari, M., Porter, D., Shi, X., Vallyathan, V., Castranova, V. and D.C. Flynn (2009). Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part. Fibre. Toxicol. 6, 1.
4. AshaRani, P.V., Low Kah Mun, G., Hande, M.P. and S. Valiyaveettil (2009). Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 3, 279-290.
5. Boczkowski, J. and P. Hoet (2010). What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature. Nanotoxicology. 4, 1-14.
6. Breimer, L.H. (1990). Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinog. 3, 188-197.
7. Buyukhatipoglu, K. and A.M. Clyne (2011). Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J. Biomed. Mater. Res. A. 96, 186-195.
8. Cacciatore, I., Caccuri, A.M., Cocco, A., De Maria, F., Di Stefano, A., Luisi, G., Pinnen, F., Ricci, G., Sozio, P. and P. Turella (2005). Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate. Amino Acids. 29, 255-261.
9. Cacciatore, I., Caccuri, A.M., Di Stefano, A., Luisi, G., Nalli, M., Pinnen, F., Ricci, G. and P. Sozio (2003). Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage. Farmaco. 58, 787-793.
10. 4/Si junctions. J. Alloys Compounds. 552, 437-442.
11. Cash, T.P., Pan, Y. and M.C. Simon (2007). Reactive oxygen species and cellular oxygen sensing. Free Radic. Biol. Med. 43, 1219-1225.
12. Choi, S.J., Oh, J.M. and J.H. Choy (2009). Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J. Inorg. Biochem. 103, 463-471.
13. Cingolani, G.M., Di Stefano, A., Mosciatti, B., Napolitani, F., Giorgioni, G., Ricciutelli, M. and F. Claudi (2000). Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-dopa. Bioorg. Med. Chem. Lett. 10, 1385-1388.
14. Di Stefano, A., D'Aurizio, E., Trubiani, O., Grande, R., Di Campli, E., Di Giulio, M., Di Bartolomeo, S., Sozio, P., Iannitelli, A., Nostro, A. and L. Cellini (2009). Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms. Microb. Biotechnol. 2, 634-641.
15. Ding, J., Tao, K., Li, J., Song, S., and K. Sun (2010). Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles. Colloids Surf. B Biointerfaces. 79, 184-190.
16. Dvir, T., Timko, B.P., Kohane, D.S., and R. Langer (2011). Nanotechnological strategies for engineering complex tissues, Nat. Nanotechnol. 6, 13-22.
17. Evans, H.J. and M.L. O'Riordan (1975). Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutat. Res. 31, 135-148.
18. Fenech, M. (1993). The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. 285, 35-44.
19. Floyd, R.A., Watson, J.J., Wong, P.K., Altmiller, D.H. and R.C. Rickard (1986). Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic. Res. Commun. 1, 163-172.
20. Foucaud, L., Wilson, M.R., Brown, D.M. and V. Stone (2007). Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol. Lett. 174, 1-9.
21. Geyikoglu, F., Turkez, H. and S.M. Keles (2005). The role of fruit juices in the prevention of aluminum sulphate toxicity in human blood in vitro. Fresen. Environ. Bull. 14, 878-883.
22. Grujic, S.M., Stojanovic, G.S., Mitic, V.D., Stankov-Jovanovic, V., Dzamic, A.M., Alimpic, A.Z. and P.D. Marin (2014). Evaluation of antioxidant activity of Melittis melissophyllum l. extracts. Arch. Biol. Sci. 66, 1401-1410.
23. Guichard, Y., Schmit, J., Darne, C., Gaté, L., Goutet, M., Rousset, D., Rastoix, O., Wrobel, R., Witschger, O., Martin, A., Fierro, V. and S. Binet (2012). Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells. Ann. Occup. Hyg. 56, 631-644.
24. Halliwell, B. (1999). Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr. Rev. 57, 104-113.
25. Haubner, K., Murawski, J., Olk, P., Eng, L.M., Ziegler, C., Adolphi, B. and E. Jaehne (2010). The route to functional graphene oxide. Chem. Phys. Chem. 11, 2131-2139.
26. Heuking, S., Iannitelli, A., Di Stefano, A. and G. Borchard (2009). Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination. Int. J. Pharm. 381, 97-105.
27. IPCS, (International Program on Chemical Safety) (1985) Environmental Health Criteria 46. Guidelines for the Study of Genetic Effects in Human Populations. 45-54, WHO, Geneva.
28. Jain, T.K., Morales, M.A., Sahoo, S.K., Leslie-Pelecky, D.L. and V. Labhasetwar (2005). Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2, 194-205.
29. Karlsson, H.L., Gustafsson, J., Cronholm, P. and L. Möller (2009). Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size. Toxicol. Lett. 188, 112-118.
30. 2 particles. Ecotoxicol. Environ. Saf. 93, 191-197.
31. Kawanishi, M., Ogo, S., Ikemoto, M., Totsuka, Y., Ishino, K., Wakabayashi, K. and T. Yagi (2013). Genotoxicity and reactive oxygen species production induced by magnetite nanoparticles in mammalian cells. J. Toxicol. Sci. 38, 503-511.
32. Könczöl, M., Ebeling, S., Goldenberg, E., Treude, F., Gminski, R., Gieré, R., Grobéty, B., Rothen-Rutishauser, B., Merfort, I. and V. Mersch-Sundermann (2011). Cytotoxicity and genotoxicity of size-fractionated Iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem. Res. Toxicol. 24, 1460-1475.
33. Kowaltowski, A.J., de Souza-Pinto, N.C., Castilho, R.F. and A.E. Vercesi (2009). Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 47, 333-343.
34. Lanone, S., Rogerieux, F., Geys, J., Dupont, A., Maillot-Marechal, E. and J. Boczkowski (2009). Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part. Fibre. Toxicol. 6, 14-19.
35. Lewerenz, V., Hanelt, S., Nastevska, C., El-Bahay, C., Röhrdanz, E. and R. Kahl (2003). Antioxidants protect primary rat hepatocyte cultures against acetaminophen-induced DNA strand breaks but not against acetaminophen-induced cytotoxicity. Toxicology. 191, 179-187.
36. Lewin, M., Carlesso, N., Tung, C.H., Tang, X.W., Cory, D., Scadden, D.T. and R. Weissleder (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414.
37. Li, S.Q., Zhu, R.R., Zhu, H., Xue, M., Sun, X.Y., Yao, S.D. and S.L. Wang (2008). Nanotoxicity of TiO(2) nanoparticles to erythrocyte in vitro. Food Chem. Toxicol. 46, 3626-3231.
38. Limbach, L.K., Wick, P., Manser, P., Grass, R.N., Bruinink, A. and W.J. Stark (2007). Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 41, 4158-4163.
39. 4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int. J. Nanomedicine. 7, 4809-4818.
40. Meng, H., Xia, T., George, S. and A.E. Nel (2009). A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano. 3, 1620-1627.
41. Metin, Ö., Kayhan, E., Özkar, S. and J.J. Schneider (2012). Palladium nanoparticles supported on chemically derived graphene: An efficient and reusable catalyst for the dehydrogenation of ammonia borane. Int. J. Hydrogen Energy. 37, 8161-8169.
42. Milovanovic, I., Stajic, M., Cilerdzic, J., Stanojkovic, T., Knezevic, A. and J. Vukojevic (2014). Antioxidant, antifungal and anticancer activity of Se-enriched Pleurotus spp. mycelium extracts. Arch. Biol. Sci. 66, 1379-1388.
43. Milto, I.V., Klementeva, T.K., Sukhodolo, I.V. and N.A. Krivova (2013). Prooxidant and antioxidant activity of blood plasma and histology of internal organs of rats after intravenous administration of magnetite nanoparticles. Biomed. Khim. 59, 330-338.
44. Park, E.J. and K. Park (2009). Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol. Lett. 184, 18-25.
45. Park, E.J., Kim, H., Kim, Y., Yi, J., Choi, K. and K. Park (2010). Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology. 275, 65-71.
46. Riehemann, K., Schneider, S.W., Luger, T.A., Godin, B., Ferrari, M. and H. Fuchs (2009). Nanomedicine-challenge and perspectives. Angew. Chem. Int. Ed. Engl. 48, 872-897.
47. Rieznichenko, L.S., Dybkova, S.M., Gruzina, T.G., Ulberg, Z.R., Todor, I.N., Lukyanova, N.Y., Shpyleva, S.I. and V.F. Chekhun (2012). Gold nanoparticles synthesis and biological activity estimation in vitro and in vivo. Exp. Oncol. 34, 25-28.
48. Rispoli, V., Rotiroti, D., Carelli, V., Liberatore, F., Scipione, L., Marra, R., Giorgioni, G. and A. Di Stefano (2004). Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or lesions of the nucleus basalis of Meynert. Neurosci. Lett. 356, 199-202.
49. Sadeghiani, N., Barbosa, L.S., Silva, L.P., Azevedo, R.B., Morais, P.C. and Z.G.M. Lacava (2005). Genotoxicity and inflammatory investigation in mice treated with magnetite nanoparticles surface coated with polyaspartic acid. J. Magn. Magn. Mater. 289, 466-468.
50. Sozio, P., D'Aurizio, E., Iannitelli, A., Cataldi, A., Zara, S., Cantalamessa, F., Nasuti, C. and A. Di Stefano (2010). Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity. Arch. Pharm. (Weinheim). 343, 133-142.
51. Sundaram, S.K., Weber, T.J., Addleman, R.S., Riley, B.J. and A.A. Schepmoes (2006). Biomarker discovery for exposure of macrophage cells to nanoparticles. 2006 NSTI Nanotechnology Conference and Trade Show, Boston.
52. Szalay, B., Tátrai, E., Nyíro, G., Vezér, T. and G. Dura (2012). Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J. Appl. Toxicol. 32, 446-453.
53. Turkez, H. (2008). Effects of boric acid and borax on titanium dioxide genotoxicity. J. Appl. Toxicol. 28, 658-664.
54. Turkez, H. and B. Togar (2010). The genotoxic and oxidative damage potential of olanzapine in vitro. Toxicol. Ind. Health. 26, 583-588.
55. Turkez, H., Geyikoglu, F. and A. Tatar (2012a). The effects of some boron compounds against heavy metal toxicity in human blood. Exp. Toxicol. Pathol. 64, 93-101.
56. Turkez, H., Aydin, E. and A. Aslan (2012b). Xanthoria elegans (Link) (lichen) extract counteracts DNA damage and oxidative stress of mitomycin C in human lymphocytes. Cytotechnol. 64, 679-686.
57. Ortega, R., Bresson, C. and C. Darolles (2014). Low-solubility particles and a Trojan-horse type mechanism of toxicity: the case of cobalt oxide on human lung cells. Particle Fibre Toxicol. 11, 14.
58. 4 magnetic nanoparticles on A549 cells. Int. J. Mol. Sci. 14, 15546-15560.
59. Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J.I., Wiesner, M.R. and A.E. Nel (2006). Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano. Lett. 6, 1794-1807.
60. Xiang, J.J., Tang, J.Q., Zhu, S.G., Nie, X.M., Lu, H.B., Shen, S.R., Li, X.L., Tang, K., Zhou, M. and G.Y. Li (2003). IONP-PLL: a novel non-viral vector for efficient gene delivery. J. Gene Med. 5, 803-817.
61. 4 hybrid composite and its application in the removal of dyes from aqueous solution. J. Mater. Chem. 22, 1033-1039.
62. Xu, Z., Shen, C., Hou, Y., Gao, H. and S. Sun (2009). Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. Chem. Mater. 21, 1778-1780.
63. 4 magnetite nanoparticles and their cytotoxicity on 4 T1 breast cancer cells. Daru. 20, 15.